Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Plos One|July 27, 2016
Rapid Discrimination of Malignant Breast Lesions from Normal Tissues Utilizing Raman Spectroscopy System: A Systematic Review and Meta-Analysis of In Vitro StudiesKe Deng, Chenjing Zhu, Xuelei Ma, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 25, 2023
Automated treatment planning for liver cancer stereotactic body radiotherapyLing He, Xingchen Peng, Na Chen, et al.International Journal of Biological Sciences|November 10, 2025
The PI3K/Akt/mTOR Pathway: Immuno-Metabolic Orchestration in IR/MASH-Associated Hepatocellular CarcinomaJian Zhao, Yuehua Zhang, Zhigong Wei, et al.Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Association between Statin Use and Survival in Cancer Patients with Brain Metastasis: Retrospective Analysis from the Chinese PopulationYu Min, Zheran Liu, Zhigong Wei, et al.Frontiers in Oncology|August 4, 2022
CT-Only Radiotherapy: An Exploratory Study for Automatic Dose Prediction on Rectal Cancer Patients Via Deep Adversarial NetworkJiaqi Cui, Zhengyang Jiao, Zhigong Wei, et al.Cell & Bioscience|October 12, 2023
Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signalingJing Jin, Qijie Zhao, Zhigong Wei, et al.Oral Oncology|August 31, 2020
Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experienceLing He, Jianghong Xiao, Zhigong Wei, et al.Frontiers in Oncology|September 11, 2023
Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization studyYu Min, Zheran Liu, Ruidan Li, et al.BMC Cancer|November 11, 2024
Multicriteria optimization achieves superior normal tissue sparing in volumetric modulated arc therapy for gastric cancerLing He, Xinrui Gao, Tao Li, et al.Cancers|September 23, 2022
Comparison of Second-Line Treatments for Patients with Platinum-Resistant Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Bayesian Network Meta-AnalysisYan He, Junsong Zeng, Zhigong Wei, et al.Pageof 6